Ontralfy Solution
Product Images NDC 69528-310

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ontralfy (NDC 69528-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rosemont Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Ontralfy 473 mL Label)

This is a description of a medication called Ontralfy™, which is an oral solution containing 2 mg of Tizanidine Hydrochloride per 5 mL. It comes in a 16 fl. oz. (473 mL) bottle and should be stored at 20°C to 25°C (68°F to 77°F). It is important to keep this medication out of reach of children. The dosage instructions can be found in the prescribing information. The medication is manufactured for Rosemont Pharmaceuticals, LLC and the trademark is owned by Fidelity Biopharma Co.*

FDA Label Image

Chemical Structure (Ontralfy 01)

FDA Label Image

Figure 1 (Ontralfy 02)

This text mentions improvement in Ashworth Score after taking 16 mg of tizanidine. It seems to be referring to a study or record of medication impact over hours post-dose.*

FDA Label Image

Figure 2 (Ontralfy 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.